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An unexpected cause of severe 
and refractory PTH-independent 
hypercalcemia: case report 
and literature review
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SUMMARY 
Hypercalcemia is a common condition in the internal medicine practice. Sometimes its cause is not 
readily apparent, so extensive investigation is appropriate. Here we report an unexpected cause for 
hypercalcemia in an elderly woman. The case of an 82-years old woman with PTH-independent hy-
percalcemia, lymphocytosis, normal serum 1,25 (OH)vitamin D levels, and low serum PTHrp levels, 
is described. Medical history and complementary investigation were unremarkable, except for in-
creased metabolic activity in the glutei regions, as measured by whole body 18F-FDG PET-CT. Re-
viewing her medical history, her sister recalled that she had been submitted to intramuscular methyl-
methacrylate injections, for cosmetic purposes, five years before presentation, which was confirmed 
by muscle biopsy. Low calcium intake, parenteral bisphosphonates, calcitonin, and glucocorticoids 
were used to control serum calcium levels. Methylmethacrylate injections, used cosmetically, are a 
new cause for hypercalcemia, even after many years. Hypercalcemia was probably due to calcitriol 
overproduction in foreign body granulomas. Persistent reactive lymphocytosis could be a clue for 
this inflammatory cause of hypercalcemia. Arch Endocrinol Metab. 2015;59(3):277-80
INTRODUCTION
H ypercalcemia is a relatively common problem in clinical practice. Sometimes the cause is not read-
ily apparent, so extensive investigation is appropriate. 
Here we report an unexpected cause for hypercalcemia 
in an elderly woman.
CASE REPORT
An 82-years old woman presented with recurrent epi-
sodes of confusion, delirium, and somnolence or stupor, 
for the past 6 months. Her previous medical history was 
unremarkable, except for previous 20 pack years smoking 
and systemic arterial hypertension. She has been using 
daily hydrochlorothiazide 25 mg, amiloride 2.5 mg, vita-
min D3 2000 IU, and calcium carbonate 2 g. There were 
no previous surgeries or hospital admissions. The physical 
exam was unremarkable, except for low BMI (17 Kg/m2). 
Initial evaluation, as shown in table 1, disclosed severe 
PTH-independent hypercalcemia, lymphocytosis, and no 
vitamin D intoxication. All her medications were stopped, 
and, as serum phosphate level was in the low reference 
range and tubular reabsorption of phosphate was low, a 
probable malignant cause was searched for. Computed to-
mography (CT) of neck, thorax, and abdomen, revealed a 
small swelling of the pyriform sinus, and simple renal and 
ovarian cysts, up to 1.2 cm; fiberoptic indirect and di-
rect laryngoscopy identified no lesion, and biopsies of the 
pyriform sinus region had no tumor; bone scintigraphy, 
bone marrow aspiration, peripheral blood cells immuno-
phenotyping, serum and urine protein electrophoresis, 
and upper gastrointestinal endoscopic study were normal. 
Transvaginal pelvic ultrasound confirmed the presence of 
a simple ovarian cyst. A whole body 18F-FDG PET-CT 
showed extensive and symmetric increased metabolic 
activity in the glutei regions, as shown in figure 1A. At 
inspection, bilateral glutei regions were normal, but ir-
regular 2-3 cm hard nodules were identified by palpation. 
The abdominal CT was reviewed with identification of 
extensive areas of increased density and loss of definition 
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Table 1. Laboratory data at admission
Result Reference range
Hemoglobin (g/dL) 11.1 11.0 – 16.0
Hematocrit (%) 33.2 35 – 47
White cells (per mL) 9,640 3,600 – 11,000
Neutrophyls (per mL) 4,400 1,500 – 7,000
Lymphocytes (per mL) 4,300 1,000 – 2,900
Platelets (1,000/mL) 188 150 – 400
Creatinine (mg/dL) 1.32 0.6 – 1.1
Sodium (mmol/L) 142 136 – 145
Potassium (mmol/L) 3.4 3.5 – 5.1
Bicarbonate (mmol/L) 27 22 – 30
Calcium (mg/dL) 13.7 8.6 – 10.0
Phosphorus (mg/dL) 2.5 2.4 – 5.1
Magnesium (mg/dL) 1.8 1.2 – 2.7
Alkaline phosphatase (U/L) 68 20 – 130
PTH (pg/mL) 2.8 14 – 72
25-OH-vitamin D (ng/mL) 15.2 > 20
AST (U/L) 31 10 – 34
ALT (U/L) 22 10 – 49
Albumin (g/dL) 3.5 3.2 – 4.8
TRP (%) 59 85 – 100
PTH: parathyroid hormone; AST: aspartate transaminase; ALT: alanine transaminase; 
TRP: tubular reabsorption of phosphate.
Reviewing the medical history, her sister recalled 
that she has been submitted to intramuscular methylme-
thacrylate injections in the glutei regions for cosmetic 
reasons, five years before presentation. A gluteus mus-
cle biopsy showed chronic inflammation with fibrosis, 
histiocytes, lymphocytes, and giant cells around foreign 
body, compatible with methylmethacrylate (Figure 2). 
A surgical consultation was made, but resection of the 
lesions was not indicated due to its extension. At this 
point serum PTHrp and calcitriol levels were availa-
ble: PTHrp: below 0.8 pmol/L (reference range < 
1.3 pmol/L; chemiluminescence); calcitriol: 34 pg/
mL (reference range 18 – 78 pg/mL; radioimmunoas-
say). Dietary calcium was reduced to 350 mg/day, and 
40 mg of oral prednisone was prescribed for 10 days and 
increased to 80 mg/day thereafter. Two weeks later, se-
rum calcium levels were within the reference range, as 
well as blood lymphocytes, so prednisone was tapered 
to 20 mg/day. During the investigation and follow-up, 
saline infusion, calcitonin, and intravenous bisphosphona-
tes were also used. These data are depicted in figure 3. 
Twelve months later, the patient had normal serum cal-
cium levels. Written informed consent was obtained to 
report this case.
Figure 1. Abnormality of glutei regions, five years after the intramuscular 
injections of methylmethacrylate. (A) Increased metabolic activity, as shown 
by 18-FDG PET-CT Study. (B) Extensive areas of increased density and loss 
of definition of the gluteus maximus, as shown by computed tomography.
Figure 2. Fibrosis and foreign body granulomatous reaction in gluteus 
muscle, five years after the intramuscular injections of methylmethacrylate. 
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Figure 3. Serum calcium corrected for albumin, peripheral blood lymphocytes, and treatment used for hypercalcemia, five years after the intramuscular 
injections of methylmethacrylate for cosmetic reasons.
DISCUSSION
In this report, a patient with PTH-independent hyper-
calcemia, and non-monoclonal persistent lymphocytosis 
is described. The investigation was negative for cancer 
and identified a PTH-independent, calcitriol-mediated 
hypercalcemia secondary to foreign body granulomas 
induced by intramuscular methylmethacrylate, with a 
good response to oral prednisone. The milk-alkali syn-
drome was excluded due to the normal serum bicar-
bonate levels at presentation. 
The most widely known granulomatous diseases 
causing hypercalcemia are tuberculosis, sarcoidosis, 
and systemic fungal infections. Hypercalcemia in the-
se situations is mostly attributed to increase in serum 
calcitriol levels, due to higher 1alfa-hydroxylase activity 
in activated macrophages (1,2), although, in some pa-
tients, hypercalcemia has been associated with PTHrp 
(3,4). In several patients with granulomatous diseases 
and hypercalcemia, serum calcitriol levels have been 
in the normal range, which are inappropriately high, 
considering the low serum PTH levels (2). In these pa-
tients, serum vitamin D levels probably did not reflect 
tissue-level vitamin D (5). 
Less commonly, other causes of granulomatous re-
actions have been associated with hypercalcemia, also 
with elevated calcitriol levels (1), as foreign body re-
action to silicone (6), paraffin (7), and talc (8). In our 
patient, hypercalcemia was very probably mediated by 
calcitriol, as serum PTH and PTHrp levels were not 
detectable (5). 
Recently four cases of hypercalcemia associated with 
methylmethacrylate injection have been described in 
Buenos Aires, Argentina (9). All patients had severe 
hypercalcemia, low or suppressed PTH levels, and high 
or inappropriately normal serum calcitriol levels (9).
Some features of the present case are not completely 
clear. Although at presentation the patient was taking 
2000 IU of vitamin D3 daily, serum 25-OH-vitamin D 
levels were low. Several factors might have contributed 
to it: irregular intake of the prescribed vitamin D, decre-
ased vitamin D absorption, and increased conversion of 
25-OH-vitamin D to its metabolites in the granulomas. 
Also, serum phosphate levels and tubular reabsorption 
of phosphate were lower than expected. Bisphosphona-
te use and malnutrition could explain the serum phos-
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At last, our patient had high normal blood lym-
phocytes count, after elevated doses of glucocorticoids, 
which are usually associated with low lymphocyte 
counts (10). As shown in figure 3, lymphocytes counts 
and serum calcium seemed to change together, which 
could be a clue to the underlying chronic inflammatory 
condition, as the cause for hypercalcemia.
In conclusion, we report a case of PTH-indepen-
dent hypercalcemia caused by foreign body granulo-
mas, five years after the cosmetic intra-muscular me-
thylmethacrylate injection in the glutei regions, with 
poor response to bisphosphonates, and good response 
to glucocorticoids and low calcium intake.
Funding source: National Council for Research and Develop-
ment, CNPq, Brazil.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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